CIK 0001682852 · Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813467528
- Phone
- 6177146500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,875,818
- in 4 filings, $33.9M under 10b5-1 plans
Net −$33,875,818. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | Andres Juan Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +7,898 | 7,898 | ||
| 2026-11-05 | Andres Juan Chief Operating Officer | Grant or award · Restricted Stock Units | +16,955 | 16,955 | ||
| 2026-10-15 | Hoge Stephen President | Option exercise 10b5-1 | +76,452 | $12.21 | $933K | 1,675,710 |
| 2026-10-15 | Hoge Stephen President | Sale 10b5-1 | −39,145 | $220.72 | $8.6M | 1,636,565 |
| 2026-10-15 | Hoge Stephen President | Option exercise · Stock Option (Right to Buy) 10b5-1 | −76,452 | 152,905 | ||
| 2026-10-14 | Hoge Stephen President | Option exercise 10b5-1 | +76,453 | $12.21 | $933K | 1,638,482 |
| 2026-10-14 | Hoge Stephen President | Sale 10b5-1 | −38,774 | $213.47 | $8.3M | 1,599,708 |
| 2026-10-14 | Hoge Stephen President | Sale 10b5-1 | −450 | $214.15 | $96K | 1,599,258 |
| 2026-10-14 | Hoge Stephen President | Option exercise · Stock Option (Right to Buy) 10b5-1 | −76,453 | 229,357 | ||
| 2026-10-05 | Mock James M Chief Financial Officer | Option exercise | +1,454 | 60,829 | ||
| 2026-10-05 | Mock James M Chief Financial Officer | Shares withheld for taxes | −704 | $190.01 | $134K | 60,125 |
| 2026-10-05 | Mock James M Chief Financial Officer | Option exercise · Restricted Stock Units | −1,454 | 0 | ||
| 2026-09-15 | Hoge Stephen President | Option exercise 10b5-1 | +76,452 | $12.21 | $933K | 1,602,310 |
| 2026-09-15 | Hoge Stephen President | Sale 10b5-1 | −40,281 | $146.07 | $5.9M | 1,562,029 |
| 2026-09-15 | Hoge Stephen President | Option exercise · Stock Option (Right to Buy) 10b5-1 | −76,452 | 305,810 | ||
| 2026-09-14 | Hoge Stephen President | Option exercise 10b5-1 | +76,453 | $12.21 | $933K | 1,566,152 |
| 2026-09-14 | Hoge Stephen President | Sale 10b5-1 | −40,294 | $144.13 | $5.8M | 1,525,858 |
| 2026-09-14 | Hoge Stephen President | Option exercise · Stock Option (Right to Buy) 10b5-1 | −76,453 | 382,262 | ||
| 2026-09-10 | Mock James M Chief Financial Officer | Option exercise 10b5-1 | +19,836 | $30.96 | $614K | 94,211 |
| 2026-09-10 | Mock James M Chief Financial Officer | Sale 10b5-1 | −19,836 | $134.49 | $2.7M | 74,375 |
Page 1 of 20 · 389 trades